Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Shaw

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 5